Annales de Biologie Clinique


Long-term automated Bayesian management of IQC results: The experience of the Lyon Hospitals Board hemostasis laboratory Volume 81, issue 2, March-April 2023


  • Figure 1
Laboratoire de Biologie Médicale Multisite (LBMMS) d’Hémostase, CHU des hospices civils de Lyon (HCL), 59 boulevard Pinel, 69677 Bron cedex
* Correspondance : F. Sobas

The Lyon Hospitals Board (HCL) hemostasis laboratory has shifted from a frequentist to a long-term Bayesian approach to IQC results management, using the Hemohub® software of the Werfen corporation, which hosts the requisite Bayesian tools. IQC plans based on supplier specifications proved effective in managing analytic risk in line with the ISO 15189 standard. Long-term Hemohub® control and monitoring has been validated by acceptable feedback from the EQA organization used by the hemostasis community.